![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 ACTELION REGISTRATION LTD (2)
02 Campus Pharma AB, (2)
03 Campus pharma AB (2)
04 GlaxoSmithKline AG (1)
05 GlaxoSmithKline leads AS (2)
06 NTC Srl (2)
07 WELLCOME FOUNDATION LTD (1)
01 Epoprostenol Sodium (10)
02 epoprostenolnatrium (2)
01 Epoprostenol 0.5Mg 1 Unit Parenteral Use (2)
02 Epoprostenol 1,5Mg 1 Unit Parenteral Use (3)
03 PULVER OCH VÄTSKA TILL INFUSIONSVÄTSKA (2)
04 Powder and liquid to the infusion fluid, resolution (4)
05 Solution (1)
01 Italy (5)
02 Norway (4)
03 Sweden (2)
04 Switzerland (1)
01 Caripul (2)
02 Epoprostenol (2)
03 Epoprostenol Campus Pharma (2)
04 Epoprostenol CampusPharma (2)
05 Flolan (3)
06 Blank (1)